Newsletter: Weekly FDA Review (10/29/2009) - Subscribe/Unsubscribe

PharmacyOneSource.comWeekly FDA Review - 29.October.2009
  1. Final Approvals (1)
  2. Rejections (0)
  3. Orphan Drug Designations (0)
  4. Recommended Approvals (0)
  5. Fast Track Status (0)
  6. Complete Response Letters (1)
  7. Tentative Approvals (0)
  8. Priority Reviews (0)
  9. New Drug Applications (0)
  10. Alerts, Recalls and Shortages (3)
Sentri7 monitors anticoagulation patients to help you comply with The Joint Commission's NPSG 3E. Get a demo.
1. Final Approvals
  1. FDA Approves Ofatumumab for CLL
    MedPage Today
6. Complete Response Letters
  1. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo New Drug Application
    PR Newswire
10. Alerts, Recalls and Shortages
  1. ALERT: Peramivir
    FDA Notice
  2. ALERT: Rituxan
    FDA Notice
  3. Qualitest Recalls All Accusure Insulin Syringes
    ASHP News

E-mail This Newsletter to a Friend

PharmacyOneSource.com Privacy Policy
Pharmacy OneSource, 7780 Elmwood Ave. Ste #210 Middleton, WI 53562
Phone: (800) 654-8395


 

<< Back

 
statistics_tracker